In last trading session, Iovance Biotherapeutics Inc (NASDAQ:IOVA) saw 12.29 million shares changing hands with its beta currently measuring 0.86. Company’s recent per share price
Iovance Biotherapeutics Inc (NASDAQ:IOVA) has a beta value of 0.86 and has seen 9.05 million shares traded in the last trading session. The company, currently
Iovance Biotherapeutics Inc (NASDAQ:IOVA)’s traded shares stood at 17.19 million during the last session, with the company’s beta value hitting 0.89. At the close of
In the last trading session, 19.95 million Iovance Biotherapeutics Inc (NASDAQ:IOVA) shares changed hands as the company’s beta touched 0.86. With the company’s per share
Iovance Biotherapeutics Inc (NASDAQ:IOVA) has a beta value of 0.86 and has seen 9.88 million shares traded in the last trading session. The company, currently
During the last session, Iovance Biotherapeutics Inc (NASDAQ:IOVA)’s traded shares were 8.72 million, with the beta value of the company hitting 0.87. At the end
In the last trading session, 7.85 million shares of the Iovance Biotherapeutics Inc (NASDAQ:IOVA) were traded, and its beta was 0.91. Most recently the company’s
Iovance Biotherapeutics Inc (NASDAQ:IOVA)’s traded shares stood at 11.91 million during the last session, with the company’s beta value hitting 0.85. At the close of
In the latest trading session,, 3.49 million Iovance Biotherapeutics Inc (NASDAQ:IOVA) shares changed hands as the company’s beta touched 0.81. With the company’s most recent
Iovance Biotherapeutics Inc (NASDAQ:IOVA) has a beta value of 0.93 and has seen 26.43 million shares traded in the last trading session. The company, currently
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne